Register entry
Catalent U.K. Swindon Zydis Limited
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 21
- Labeller names
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
2121 active NDC listings: 21 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 21.
| Dosage form | NDCs |
|---|---|
| tablet, orally disintegrating | 12 |
| tablet | 9 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| catalent u.k. swindon zydis limited | 16 |
| catalent uk swindon zydis limited | 3 |
| catalent u.k. swindon zydis limited | 2 |
Catalogue
Marketed products
21| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Asenapine Maleate | tablet | 62938-0016DRUG FOR FURTHER PROCESSING |
| - | Asenapine Maleate | tablet | 62938-0040DRUG FOR FURTHER PROCESSING |
| - | Asenapine Maleate | tablet | 62938-0041DRUG FOR FURTHER PROCESSING |
| - | Asenapine Maleate | tablet | 62938-0045DRUG FOR FURTHER PROCESSING |
| - | Asenaprine Maleate | tablet | 62938-0035DRUG FOR FURTHER PROCESSING |
| - | Asenaprine Maleate | tablet | 62938-0039DRUG FOR FURTHER PROCESSING |
| - | Fingolimod Lauryl Sulfate | tablet, orally disintegrating | 62938-0043DRUG FOR FURTHER PROCESSING |
| - | Fingolimod Lauryl Sulfate | tablet, orally disintegrating | 62938-0044DRUG FOR FURTHER PROCESSING |
| - | GLYCOPYRROLATE | tablet, orally disintegrating | 62938-0042DRUG FOR FURTHER PROCESSING |
| - | Loratadine | tablet, orally disintegrating | 62938-0004DRUG FOR FURTHER PROCESSING |
| - | Loratadine | tablet, orally disintegrating | 62938-0005DRUG FOR FURTHER PROCESSING |
| - | Odactra | tablet | 62938-0036DRUG FOR FURTHER PROCESSING |
| - | Olanzapine | tablet, orally disintegrating | 62938-0030DRUG FOR FURTHER PROCESSING |
| - | Olanzapine | tablet, orally disintegrating | 62938-0032DRUG FOR FURTHER PROCESSING |
| - | Olanzapine | tablet, orally disintegrating | 62938-0033DRUG FOR FURTHER PROCESSING |
| - | Olanzapine | tablet, orally disintegrating | 62938-0034DRUG FOR FURTHER PROCESSING |
| - | RIMEGEPANT SULFATE | tablet, orally disintegrating | 62938-0037DRUG FOR FURTHER PROCESSING |
| - | Rizatriptan | tablet, orally disintegrating | 62938-0046DRUG FOR FURTHER PROCESSING |
| - | Short Ragweed Pollen Allergen Extract | tablet | 62938-0028DRUG FOR FURTHER PROCESSING |
| - | Timothy Grass Pollen Allergen Extract | tablet | 62938-0027DRUG FOR FURTHER PROCESSING |
| - | selegiline hydrochloride | tablet, orally disintegrating | 62938-0029DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing asenapine maleate
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Olon USA LLC11 sites · 185 NDC
- Allergan, Inc.7 sites · 187 NDC
- Medichem SA5 sites · 43 NDC
- Aspen Oss B.V.1 site · 46 NDC
- MSN Organics Private Limited1 site · 30 NDC
Enquiry
Common questions
- Is Catalent U.K. Swindon Zydis Limited FDA approved?
- Catalent U.K. Swindon Zydis Limited holds no registered establishment of its own; 21 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Catalent U.K. Swindon Zydis Limited make?
- 21 products are listed under Catalent U.K. Swindon Zydis Limited in the openFDA NDC Directory, most often as tablet, orally disintegrating; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.